761033Orig1s000
Dosing and Administration
CINQAIR® (reslizumab) Injection – About Asthma Control
Cinqair: Package Insert - Drugs.com
Administering CINQAIR.
CINQAIR® (reslizumab) Injection – About CINQAIR
hcp.cinqair.com
Product Monograph Template - Schedule D]
including co-pays, co-insurance, and deductibles.*
CINQAIR® (reslizumab) Injection – About Asthma Control
A program supporting CINQAIR® (reslizumab) Injection patients
CINQAIR - Teva Pharmaceutical Industries Limited Trademark Registration
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
test-placeholder-02.png
How patients use CINQAIR® (reslizumab) Injection Cost Support Program Card
Teva gets EU nod for severe asthma drug Cinqaero - PMLiVE
Reslizumab (Cinqair) Approved to Treat Severe Asthma | RT
Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients
Drug Analysis: Cinqair - Research and Markets
Subcutaneous Cinqair results add to Teva's troubles
CINQAIR® (reslizumab) Injection - Savings and Support
